Cargando…

High prevalence of carpal tunnel syndrome in individuals with rare nerve growth factor-beta mutation

In Sweden, a large family with a point mutation in the nerve growth factor-beta gene has previously been identified. The carriers of this mutation have reduced small-fibre density and selective deficits in deep pain and temperature modalities. The clinical findings in this population are described a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ridderström, Mikael, Svantesson, Mats, Thorell, Oumie, Magounakis, Theofilos, Minde, Jan, Olausson, Håkan, Nagi, Saad S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472894/
https://www.ncbi.nlm.nih.gov/pubmed/32954334
http://dx.doi.org/10.1093/braincomms/fcaa085
_version_ 1783579075858661376
author Ridderström, Mikael
Svantesson, Mats
Thorell, Oumie
Magounakis, Theofilos
Minde, Jan
Olausson, Håkan
Nagi, Saad S
author_facet Ridderström, Mikael
Svantesson, Mats
Thorell, Oumie
Magounakis, Theofilos
Minde, Jan
Olausson, Håkan
Nagi, Saad S
author_sort Ridderström, Mikael
collection PubMed
description In Sweden, a large family with a point mutation in the nerve growth factor-beta gene has previously been identified. The carriers of this mutation have reduced small-fibre density and selective deficits in deep pain and temperature modalities. The clinical findings in this population are described as hereditary sensory and autonomic neuropathy type V. The purpose of the current study was to investigate the prevalence of carpal tunnel syndrome in hereditary sensory and autonomic neuropathy type V based on clinical examinations and electrophysiological measurements. Furthermore, the cross-sectional area of the median nerve at the carpal tunnel inlet was measured with ultrasonography. Out of 52 known individuals heterozygous for the nerve growth factor-beta mutation in Sweden, 23 participated in the current study (12 males, 11 females; mean age 55 years; range 25–86 years). All participants answered a health questionnaire and underwent clinical examination followed by median nerve conduction study in a case–control design, and measurement of the nerve cross-sectional area with ultrasonography. The diagnosis of carpal tunnel syndrome was made based on consensus criteria using patient history and nerve conduction study. The prevalence of carpal tunnel syndrome in the hereditary sensory and autonomic neuropathy group was 35% or 52% depending on whether those individuals who had classic symptoms of carpal tunnel syndrome but negative nerve conduction studies were included or not. Those who had a high likelihood of carpal tunnel syndrome based on classic/probable patient history with positive nerve conduction study had a significantly larger median nerve cross-sectional area than those who had an unlikely patient history with negative nerve conduction study. The prevalence of carpal tunnel syndrome was 10–25 times higher in individuals heterozygous for the nerve growth factor-beta mutation than the general Swedish population. Further studies are needed to better understand the underlying pathophysiological mechanisms.
format Online
Article
Text
id pubmed-7472894
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-74728942020-09-17 High prevalence of carpal tunnel syndrome in individuals with rare nerve growth factor-beta mutation Ridderström, Mikael Svantesson, Mats Thorell, Oumie Magounakis, Theofilos Minde, Jan Olausson, Håkan Nagi, Saad S Brain Commun Original Article In Sweden, a large family with a point mutation in the nerve growth factor-beta gene has previously been identified. The carriers of this mutation have reduced small-fibre density and selective deficits in deep pain and temperature modalities. The clinical findings in this population are described as hereditary sensory and autonomic neuropathy type V. The purpose of the current study was to investigate the prevalence of carpal tunnel syndrome in hereditary sensory and autonomic neuropathy type V based on clinical examinations and electrophysiological measurements. Furthermore, the cross-sectional area of the median nerve at the carpal tunnel inlet was measured with ultrasonography. Out of 52 known individuals heterozygous for the nerve growth factor-beta mutation in Sweden, 23 participated in the current study (12 males, 11 females; mean age 55 years; range 25–86 years). All participants answered a health questionnaire and underwent clinical examination followed by median nerve conduction study in a case–control design, and measurement of the nerve cross-sectional area with ultrasonography. The diagnosis of carpal tunnel syndrome was made based on consensus criteria using patient history and nerve conduction study. The prevalence of carpal tunnel syndrome in the hereditary sensory and autonomic neuropathy group was 35% or 52% depending on whether those individuals who had classic symptoms of carpal tunnel syndrome but negative nerve conduction studies were included or not. Those who had a high likelihood of carpal tunnel syndrome based on classic/probable patient history with positive nerve conduction study had a significantly larger median nerve cross-sectional area than those who had an unlikely patient history with negative nerve conduction study. The prevalence of carpal tunnel syndrome was 10–25 times higher in individuals heterozygous for the nerve growth factor-beta mutation than the general Swedish population. Further studies are needed to better understand the underlying pathophysiological mechanisms. Oxford University Press 2020-06-25 /pmc/articles/PMC7472894/ /pubmed/32954334 http://dx.doi.org/10.1093/braincomms/fcaa085 Text en © The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ridderström, Mikael
Svantesson, Mats
Thorell, Oumie
Magounakis, Theofilos
Minde, Jan
Olausson, Håkan
Nagi, Saad S
High prevalence of carpal tunnel syndrome in individuals with rare nerve growth factor-beta mutation
title High prevalence of carpal tunnel syndrome in individuals with rare nerve growth factor-beta mutation
title_full High prevalence of carpal tunnel syndrome in individuals with rare nerve growth factor-beta mutation
title_fullStr High prevalence of carpal tunnel syndrome in individuals with rare nerve growth factor-beta mutation
title_full_unstemmed High prevalence of carpal tunnel syndrome in individuals with rare nerve growth factor-beta mutation
title_short High prevalence of carpal tunnel syndrome in individuals with rare nerve growth factor-beta mutation
title_sort high prevalence of carpal tunnel syndrome in individuals with rare nerve growth factor-beta mutation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472894/
https://www.ncbi.nlm.nih.gov/pubmed/32954334
http://dx.doi.org/10.1093/braincomms/fcaa085
work_keys_str_mv AT ridderstrommikael highprevalenceofcarpaltunnelsyndromeinindividualswithrarenervegrowthfactorbetamutation
AT svantessonmats highprevalenceofcarpaltunnelsyndromeinindividualswithrarenervegrowthfactorbetamutation
AT thorelloumie highprevalenceofcarpaltunnelsyndromeinindividualswithrarenervegrowthfactorbetamutation
AT magounakistheofilos highprevalenceofcarpaltunnelsyndromeinindividualswithrarenervegrowthfactorbetamutation
AT mindejan highprevalenceofcarpaltunnelsyndromeinindividualswithrarenervegrowthfactorbetamutation
AT olaussonhakan highprevalenceofcarpaltunnelsyndromeinindividualswithrarenervegrowthfactorbetamutation
AT nagisaads highprevalenceofcarpaltunnelsyndromeinindividualswithrarenervegrowthfactorbetamutation